We are live on
!
Find out more
CLC
Charles-Lim Capital Portfolio holdings
AUM
$319M
1-Year Est. Return
13.77%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
-13.77%
3 Year Est. Return
+4.44%
5 Year Est. Return
-59.29%
10 Year Est. Return
+482.41%
AUM
$341M
AUM Growth
-$23.6M
(-6.5%)
Cap. Flow
-$13.4M
Cap. Flow
% of AUM
-3.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICICI Bank
IBN
|
+$25.9M |
| 2 |
Dr. Reddy's Laboratories
RDY
|
+$14.5M |
| 3 |
HDFC Bank
HDB
|
+$6.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$60.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 57.31% |
| 2 | Consumer Discretionary | 38.14% |
| 3 | Healthcare | 4.56% |
Similar funds
TPW
SFS
WI
BFS
BPFA
CWA
SC
BMCM
Charles-Lim Capital's Q4 2018 Portfolio in Review
As of Q4 2018, Charles-Lim Capital held 5 positions worth $341M, down 6.5% from $364M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Charles-Lim Capital withdrew a net $13.4M in Q4 2018, closing 1 position. Its most notable exit was Alibaba, an estimated $60.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 57% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Charles-Lim Capital opened a new position in ICICI Bank worth $28.3M.
- Charles-Lim Capital's largest Q4 2018 buy was ICICI Bank: 2,746,482 shares worth $28.3M.
- Charles-Lim Capital added most to HDFC Bank in Q4 2018, an estimated $6.62M increase.
- Charles-Lim Capital fully exited Alibaba in Q4 2018, selling an estimated $60.5M.
- Charles-Lim Capital's ten largest holdings make up 100% of its $341M portfolio in Q4 2018.
- Charles-Lim Capital opened 2 new positions and closed 1 in Q4 2018.
- Charles-Lim Capital's portfolio value fell 6.5% quarter-over-quarter to $341M.
Based on Charles-Lim Capital's 13F filing for Q4 2018, filed 14 Feb 2019.